1. |
Glimelius B, Pahlman L, Cervantes A, et al. Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol, 2010, 21 Suppl 5: v82-v86.
|
2. |
NCCN. Clinical practice guidelines in oncology. Rectal cancer, Version 2. 2017. https://www.nccn.org/.
|
3. |
Sebag-Montefiore D, Stephens RJ, Steele R, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet, 2009, 373(9666): 811-820.
|
4. |
Swedish Rectal Cancer Trial, Cedermark B, Dahlberg M, et al. Improved survival with preoperative radiotherapy in resectable rectal cancer. N Engl J Med, 1997, 336(14): 980-987.
|
5. |
van Gijn W, Marijnen CA, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol, 2011, 12(6): 575-582.
|
6. |
Ansari N, Solomon MJ, Fisher RJ, et al. Acute adverse events and postoperative complications in a randomized trial of preoperative short-course radiotherapy versus long-course chemoradiotherapy for T3 adenocarcinoma of the rectum: trans-tasman radiation oncology group trial (TROG 01.04). Ann Surg, 2017, 265(5): 882-888.
|
7. |
申丽君, 章真. 局部进展期直肠癌的放疗规范及其进展. 中华胃肠外科杂志, 2016, 19(6): 618-620.
|
8. |
陈琼, 宋国慧, 孙喜斌, 等. 2003~2007 年中国结直肠癌发病与死亡分析. 中国肿瘤, 2012, 21(3): 179-182.
|
9. |
丘嘉煌, 李燕, 李科, 等. 广州市 2004-2013 年结直肠癌发病趋势分析. 广东医学, 2016, 37(22): 3334-3337.
|
10. |
Ngan SY, Burmeister B, Fisher RJ, et al. Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04. J Clin Oncol, 2012, 30(31): 3827-3833.
|
11. |
Franke AJ, Parekh H, Starr JS, et al. Total neoadjuvant therapy: a shifting paradigm in locally advanced rectal cancer management. Clin Colorectal Cancer, 2017, [Epub ahead of print].
|
12. |
Bujko K, Nowacki MP, Nasierowska-Guttmejer A, et al. Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg, 2006, 93(10): 1215-1223.
|
13. |
Watanabe T, Itabashi M, Shimada Y, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. Int J Clin Oncol, 2012, 17(1): 1-29.
|
14. |
Watanabe T, Itabashi M, Shimada Y, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer. Int J Clin Oncol, 2015, 20(2): 207-239.
|
15. |
Watanabe T, Muro K, Ajioka Y, et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer. Int J Clin Oncol, 2017, [Epub ahead of print].
|
16. |
Pettersson D, Cedermark B, Holm T, et al. Interim analysis of the StockholmⅢ trial of preoperative radiotherapy regimens for rectal cancer. Br J Surg, 2010, 97(4): 580-587.
|
17. |
Pettersson D, Glimelius B, Iversen H, et al. Impaired postoperative leucocyte counts after preoperative radiotherapy for rectal cancer in the Stockholm Ⅲ Trial. Br J Surg, 2013, 100(7): 969-975.
|
18. |
Deng Y, Chi P, Lan P, et al. Modified FOLFOX6 with or without radiation versus fluorouracil and leucovorin with radiation in neoadjuvant treatment of locally advanced rectal cancer: initial results of the Chinese FOWARC multicenter, open-label, randomized three-arm phaseⅢ Trial. J Clin Oncol, 2016, 34(27): 3300-3307.
|
19. |
Pettersson D, Holm T, Iversen H, et al. Preoperative short-course radiotherapy with delayed surgery in primary rectal cancer. Br J Surg, 2012, 99(4): 577-583.
|
20. |
Wang ZQ, Deng XB, Liu P, et al. Neoadjuvant radiotherapy vs. surgery alone for stage Ⅱ/Ⅲ mid-low rectal cancer with or without high risk factors: a multicenter randomized trial. J Clin Oncol, 2017, 35: 3537.
|
21. |
Slagsvold JE, Viset T, Wibe A, et al. Radiation therapy did not induce long-term changes in rectal mucosa: results from the randomized scandinavian prostate cancer group 7 trial. Int J Radiat Oncol Biol Phys, 2016, 95(4): 1268-1272.
|